Cervical Disc Disease
Conditions
Brief summary
Prostheses use subsequently became prevalent and a number of studies were conducted. However, prosthesis-associated heterotropic ossification (HO) in the segments with prostheses was reported in 2005, which disrupted mobility and caused fusion. In the present study, we aimed to investigate the clinical outcomes, HO incidence, and prosthesis mobility in the patients following the operative use of Alpha-D disc prosthesis as developed and used by the authors to treat cervical disk diseases.
Interventions
Alpha-D cervical disc prosthesis was developed jointly by the Spine Center of Koç University Faculty of Medicine and Toledo University Bioengineering Department. It was designed as a single unit to ensure user-friendly administration for surgeons, and it was designed and manufactured to reproduce the movements of the normal cervical movement segment.
Sponsors
Study design
Eligibility
Inclusion criteria
* cervical disc hernia * underwent cervical discectomy and received cervical disc prostheses
Exclusion criteria
* history of cervical surgery, * kyphotic deformity, * rheumatological or other systemic diseases, * severe osteophytes caused by advanced degenerative disc disease * severe spinal stenosis
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Heterotropic ossification | Postoperative 18-78.months | McAfee-Mehren classification |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| visual analog scale | 4 and 12 months after surgery | (0-10, 0=no pain, 10=extreme pain) |
| neck disability index | 4 and 12 months after surgery | The questionnaire has 10 items concerning pain and activities of daily living including personal care, lifting, reading, headaches, concentration, work status, driving, sleeping and recreation. |
Countries
Turkey (Türkiye)